CEO Interview
Pluristem Therapeutics, Inc. (NASDAQ: PSTI) Regenerative medicine technologies for billion dollar markets
Pluristem Therapeutics, Inc. (NASDAQ: PSTI), interview with co-CEO Yaky Yanay. Yaky explains Pluristem’s regenerative medicine technologies, which use placenta-derived cell products, and address multi-billion health markets. Pluristem has 3 […]